Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are aryl hydrocarbon receptor agonists, pharmaceutical compositions, use of such compounds in treating immune-mediated diseases, in particular, psoriasis, and processes for preparing such compounds.
Keyphrases